These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 29384123

  • 1. [Comparative study of the conventional scheme and prolonged treatment with steroids on primary steroid-sensitive nephrotic syndrome in children].
    Liern M, Codianni P, Vallejo G.
    Bol Med Hosp Infant Mex; 2016; 73(5):309-317. PubMed ID: 29384123
    [Abstract] [Full Text] [Related]

  • 2. Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial.
    Sheikh S, Mishra K, Kumar M.
    Pediatr Nephrol; 2021 Oct; 36(10):3143-3150. PubMed ID: 33861375
    [Abstract] [Full Text] [Related]

  • 3. [Rituximab treatment in pediatric patients with steroid-dependent nephrotic syndrome: a tertiary hospital].
    Guzmán Morais B, Ordóñez Álvarez FÁ, Santos Rodríguez F, Martín Ramos S, Fernández Novo G.
    An Pediatr (Engl Ed); 2021 Jan 28. PubMed ID: 33518484
    [Abstract] [Full Text] [Related]

  • 4. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N, Kim S, Craig J, Hodson E.
    Arch Dis Child; 2016 Apr 28; 101(4):404-8. PubMed ID: 26289063
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of a Low Dose Prednisolone Regimen for Treatment of Relapses in Children with Steroid Sensitive Nephrotic Syndrome.
    Mantan M, Kansal A, Swarnim S.
    Indian J Nephrol; 2022 Apr 28; 32(6):588-594. PubMed ID: 36704589
    [Abstract] [Full Text] [Related]

  • 6. Steroid-sensitive nephrotic syndrome: from childhood to adulthood.
    Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grünfeld JP, Niaudet P.
    Am J Kidney Dis; 2003 Mar 28; 41(3):550-7. PubMed ID: 12612977
    [Abstract] [Full Text] [Related]

  • 7. [Idiopathic nephrotic syndrome in children: Incidence, clinical presentation, and outcome in the county of Gironde, France].
    Ernould S, Godron A, Nelson JR, Rigothier C, Llanas B, Harambat J.
    Arch Pediatr; 2011 May 28; 18(5):522-8. PubMed ID: 21458969
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
    Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
    Nephrology (Carlton); 2016 Jan 28; 21(1):21-7. PubMed ID: 26697959
    [Abstract] [Full Text] [Related]

  • 9. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
    Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A.
    Kidney Int; 2015 Jan 28; 87(1):217-24. PubMed ID: 25029428
    [Abstract] [Full Text] [Related]

  • 10. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
    Mishra OP, Thakur N, Mishra RN, Prasad R.
    J Nephrol; 2012 Jan 28; 25(3):394-400. PubMed ID: 21928226
    [Abstract] [Full Text] [Related]

  • 11. Predictive risk factors of steroid dependent nephrotic syndrome in children.
    Abdel-Hafez MA, Abou-El-Hana NM, Erfan AA, El-Gamasy M, Abdel-Nabi H.
    J Nephropathol; 2017 Jul 28; 6(3):180-186. PubMed ID: 28975099
    [Abstract] [Full Text] [Related]

  • 12. Relapse treatment with low-dose steroids in steroid-sensitive minimal change disease.
    Martin Capon I, Gutierrez E, Huerta A, Viera E, Alvarez Nadal M, Fernández-Lucas M, Villacorta J.
    Front Nephrol; 2024 Jul 28; 4():1426156. PubMed ID: 39055858
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
    Skrzypczyk P, Panczyk-Tomaszewska M, Roszkowska-Blaim M, Wawer Z, Bienias B, Zajgzkowska M, Kilis-Pstrusinska K, Jakubowska A, Szczepaniak M, Pawlak-Bratkowska M, Tkaczyk M.
    Clin Nephrol; 2014 Mar 28; 81(3):166-73. PubMed ID: 24361057
    [Abstract] [Full Text] [Related]

  • 14. Plasma levels of oxidative stress in children with steroid-sensitive nephrotic syndrome and their predictive value for relapse frequency.
    Fan A, Jiang X, Mo Y, Tan H, Jiang M, Li J.
    Pediatr Nephrol; 2016 Jan 28; 31(1):83-8. PubMed ID: 26341250
    [Abstract] [Full Text] [Related]

  • 15. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
    Bagga A, Hari P, Srivastava RN.
    Pediatr Nephrol; 1999 Nov 28; 13(9):824-7. PubMed ID: 10603129
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P.
    Nephrol Dial Transplant; 1993 Nov 28; 8(12):1326-32. PubMed ID: 8159300
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Nov 28; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.